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The postsynaptic density contains multiple protein
complexes that together relay the presynaptic neuro-
transmitter input to the activation of the postsynaptic
neuron. In the present study we took two independent
proteome approaches for the characterization of the
protein complement of the postsynaptic density, namely
1) two-dimensional gel electrophoresis separation of
proteins in conjunction with mass spectrometry to iden-
tify the tryptic peptides of the protein spots and 2) iso-
lation of the trypsin-digested sample that was labeled
with isotope-coded affinity tag, followed by liquid chro-
matography-tandem mass spectrometry for the partial
separation and identification of the peptides, respec-
tively. Functional grouping of the identified proteins
indicates that the postsynaptic density is a structurally
and functionally complex organelle that may be in-
volved in a broad range of synaptic activities. These
proteins include the receptors and ion channels for glu-
tamate neurotransmission, proteins for maintenance
and modulation of synaptic architecture, sorting and
trafficking of membrane proteins, generation of anaer-
obic energy, scaffolding and signaling, local protein syn-
thesis, and correct protein folding and breakdown of
synaptic proteins. Together, these results imply that the
postsynaptic density may have the ability to function
(semi-) autonomously and may direct various cellular
functions in order to integrate synaptic physiology.
The majority of excitatory neurotransmission in the brain
occurs via glutamatergic synapses. In the presynaptic element
of the synapse, specialized secretion machinery determines the
activity-dependent membrane fusion of glutamate-containing
vesicles and the release of transmitter into the synaptic cleft.
In the postsynaptic element, glutamate receptors and down-
stream signal transduction are organized by the protein assem-
bly of the postsynaptic density (PSD).1 Both the presynaptic
release machinery and the PSD are electron-dense assemblies
(1, 2), in which proteins are thought to be organized into dis-
tinct functional complexes (3–5) that may be dynamically reg-
ulated by neuronal activity (6–8). The modulation of this mo-
lecular architecture of the synapse is at the basis of synaptic
plasticity (6–8), and aberrations thereof may underlie neuro-
nal disorders.
In view of the importance of the PSD in glutamatergic neu-
rotransmission and its involvement in neuroplasticity, consid-
erable efforts have been made to identify its protein constitu-
ents as a prelude to understand the molecular basis of PSD
functioning. In the past several years, yeast two-hybrid tech-
nology has been extensively used to characterize proteins that
interact with the glutamate receptors and may constitute core
elements of the PSD involved in the regulation of receptor
trafficking and signaling (reviewed in Refs. 9–11). Based
largely on these studies a protein-protein interaction map of
the PSD has emerged. In brief, the model posits that the
postsynaptic receptor complexes are localized by scaffolding
proteins such as the synapse-associated protein (SAP) 90 (also
known as PSD-95). These proteins link the receptors to various
signaling molecules e.g. nitric-oxide synthase, calcium/calmod-
ulin-dependent protein kinase II (CaMKII), and inositol 1,4,5-
trisphosphate receptors. Receptors and scaffolding proteins are
further linked to cytoskeletal proteins, the arrangement of
which will determine the morphology of and protein trafficking
in the spine.
Yeast two-hybrid experiments are particularly useful in the
detection of pairwise protein interactions, but are limited in
their ability to reveal the global protein constituents of the
protein complexes/organelles of interest. Alternatively, several
PSD proteins have been identified from protein complexes by
conventional biochemical means (12) or via the generation of
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antibodies against the protein complex for screening of the
expression library (13). For a global analysis of proteins the
recently developed mass spectrometric-based proteome ap-
proach is particular attractive because hundreds of proteins
can be displayed and identified. The large dataset generated
can be used to formulate hypotheses and in turn design exper-
iments to understand the (distinct) physiological processes car-
ried out by the differentially composed protein complexes. Re-
cently, several large scale proteome and proteomics studies
have been reported (4–5, 14–18).
One of the first applications of proteome research in neuro-
science was aimed at the characterization of novel PSD pro-
teins (18). The PSD fraction was isolated using a standard
protocol developed by Carlin et al. (19). The PSD proteins were
partially separated on an SDS electrophoresis gel, trypsinized,
and then characterized based on their peptide mass fingerprint
(PMF). About thirty proteins, including “classic” and novel PSD
proteins, were successfully elucidated. Overall, the number of
proteins identified was lower than that expected, which may
amount to above a hundred (4, 9–10). This suggested that a
considerable number of PSD proteins remained to be
characterized.
In this study we aimed at a much higher coverage of the PSD
protein content in order to reveal groups of proteins that would
predict novel synaptic functions. We employed two methods for
the separation and detection of the proteins, namely (a) high-
load preparative two-dimensional gel electrophoresis to sepa-
rate a larger number of PSD proteins with increased resolu-
tion, and identified the tryptic peptides of individual protein
spots by matrix-assisted laser desorption/ionization time-of-
flight/time-of-flight mass spectrometer (MALDI TOF/TOF®
MS), (b) isotope-coded affinity tagging (ICAT) of the proteins
followed by trypsin digestion and the separation of cysteine-
containing peptides by nano-liquid chromatography (LC) cou-
pled online to an electrospray quadrupole-TOF mass spectrom-
eter for the identification of the peptides (20). A large number
of previously identified PSD proteins, as well as novel groups of
proteins, were detected. Western blotting analysis of proteins
from selected functional groups confirmed the enrichment of
these proteins in the PSD. Grouping of the proteins based on
their functions indicated protein complexes that are involved in
diverse physiological activities, e.g. the receptors and ion chan-
nels, protein synthesis and breakdown, scaffolding, signal
transduction etc. The wide diversity of proteins that may be
active in the PSD clearly indicates the PSD to be the organizer
of spine functioning sustaining the emerging view (21–22) that
considers the dendritic spine as the smallest self-sustaining
(semi)-autonomous neuronal organelle.
EXPERIMENTAL PROCEDURES
Purification of the PSD—The PSD fraction was isolated either as
described (23) based on the original method of Carlin et al. (19), or based
largely on a variant of the original method (24). In brief, in the original
method, forebrains of 30 days old untreated rats were homogenized in
homogenization buffer (5 mM Hepes, pH 7.4; 320 mM sucrose) contain-
ing a protease inhibitor mixture (Roche Applied Science). Cell debris
and nuclei were removed by 1,000  g centrifugation. The supernatant
was spun for 20 min at 12,000  g, resulting in supernatant and pellet
P2. The P2 pellet was further fractionated by centrifugation in a sucrose
step gradient to obtain the synaptosome, an organelle that contains
both pre- and postsynaptic compartments. Synaptosome was lysed in
hypotonic solution to release the cytoplasmic proteins and organelles
such as mitochondria and small synaptic vesicle, and the resulting
synaptic membrane was recovered by centrifugation using the sucrose
gradient as stated above. For isolation of the PSD fraction, the synaptic
membrane was diluted with 12 mM Tris-HCl (pH 8.1), 320 mM sucrose
and an equal volume of 1% Triton X-100, 320 mM sucrose. The suspen-
sion was stirred for 15 min and then centrifuged for 30 min at 33,000 
g. The pellet was resuspended in 320 mM sucrose, 0.5% Triton X-100, 5
mM Tris/HCl, pH 8.1. After 15 min of stirring, the PSD proteins were
pelleted by a 2-h centrifugation at 201,800  g. All steps were carried
out at 4 °C. This PSD preparation was used for all the two-dimensional
gel experiments.
In the variant method, the synaptic membrane was isolated as de-
scribed above, and stirred for 30 min over ice in 1% Triton X-100 in 50
mM Hepes (pH 7.4). After centrifugation for 15 min at 30,000  g, the
pellet was suspended in 320 mM sucrose in Hepes buffer and loaded on
top of a sucrose gradient consisting of 1 M, 1.5 M, and 2 M sucrose. The
sample was centrifuged at 100,000  g for 2 h, and the interface
between 1.5 and 2 M was collected, mixed with equal volume of water
containing 2% Triton X-100 and 150 mM KCl, and loaded directly on top
of a sucrose gradient of 1.5/2 M. The gradient was centrifuged at
100,000  g for 1 h. The interface at 1.5/2 M sucrose was collected,
diluted 2with water, and centrifuged to obtain the PSD fraction. After
washing once with water, the pellet was redissolved in 0.5% SDS and
then used for ICAT labeling, trypsin digestion, and liquid chromatog-
raphy-tandem mass spectrometry studies.
Two-dimensional Gel Electrophoresis—Two-dimensional gel electro-
phoresis was carried out as described (25). In brief, samples were
solubilized in lysis buffer for 30 min (9 M urea, 2% CHAPS, 20 mM Tris,
pH 7.5, 0.5% dithiothreitol, and 0.5% IPG buffer 3–10) and then cen-
trifuged. 370 l of the supernatant was used for the rehydration and
simultaneously loading of the proteins to the IPG strip (Immobiline 18
cm DryStrip 3–10 NL, Amersham Biosciences), at 30 V for 12 h. The
voltage was increased to 8000 V and focused for a total of 65,000 V/hr.
Immediately after being focused, IPG strips were wrapped in plastic foil
and stored at80 °C. Prior to SDS-PAGE, IPG strips were equilibrated
in 6 M urea/2% SDS/1% dithiothreitol/50 mM Tris, pH 8.8/30% glycerol
for 15 min, followed by equilibration in 6 M urea/2% SDS/2.5% iodo-
acetamide/50 mM Tris, pH 8.8/30% glycerol for 15 min. The second
dimension separation was run overnight using the Isodalt System (Am-
ersham Biosciences) in 1.5-mm 11% gels (Duracryl, Genomic Solutions)
at 25 mA per gel at 15 °C. After electrophoresis, gels were fixed and
stained using either silver or colloidal Coomassie Brilliant Blue G-250.
The gels were washed once with water and stored at room temperature
in a plastic sealing until tryptic digestion.
Digestion of Proteins from Two-dimensional Gels—All the visible
protein spots from the Coomassie Blue-stained gel were manually ex-
cised with a round bottom dermal slicer of 3-mm diameter. The gel
pieces were destained in 60% acetonitrile in 25 mM ammonium bicar-
bonate buffer, pH 8.5, and then dehydrated with 100% acetonitrile. The
shrunken gel pieces were reswelled in 25 mM ammonium bicarbonate
buffer, dehydrated again in 100% acetonitrile, and dried in a speedvac.
For gel pieces that were heavily stained the rehydration/dehydration
step was repeated once. The gel pieces were rehydrated in 8 l of
trypsin solution (20 g/ml) for 1 h, followed by addition of 50 l of 25 mM
ammonium bicarbonate buffer to completely immerse the gel pieces.
After incubation overnight at room temperature, 0.5 l of the incuba-
tion buffer was pipetted to the MALDI plate and mixed with 1 l of
-cyano-4-hydroxycinnamic acid. The samples were analyzed by a
MALDI TOF/TOF® (Applied Biosystems) mass spectrometer (see be-
low). In cases where the mass spectrometric signals were weak, the
incubation buffer was loaded into a C18 Ziptip (Millipore) according to
the protocol provided by the company. The bound peptides were eluted
from the Ziptip using 1.0 l of -cyano-4-hydroxycinnamic acid, which
was directly deposited onto the MALDI plate. The -cyano-4-hydroxy-
cinnamic acid matrix concentration was 5 mg/ml in 50% acetonitrile/
50% water containing 0.1% trifluoroacetic acid.
For the identification of (the abundant) proteins from the silver
stained gel, protein spots were digested as stated above. After incuba-
tion with trypsin the supernatant was loaded into a self-packed Poros
R2 (PerSeptive Biosystems) micro-tip, and eluted in 5 l 50% acetroni-
trile/1% formic acid directly into a spraying electrode and analyzed by
an electrospray Q-TOF (Micromass) mass spectrometer as described
previously (26) and below.
Immunoblots—P2, synaptosome, synaptic membrane and PSD
fraction were lysed in two-dimensional gel electrophoresis lysis
buffer, except that the IPG buffer and bromphenol blue were omitted
from the lysis buffer. Protein concentrations were determined by
Bradford assay. Equal volume of the extract was mixed with 2 SDS
buffer, boiled for 2 min, and 10 g was loaded to a 10% mini SDS-gel.
Electrophoresis was carried out at 120 V for 1 h, and the proteins
were electrotransblotted to nitrocellulose membrane in the CAPSO
buffer containing 10% methanol at 30V overnight. The membranes
were blocked in 2% bovine serum albumin in Tris-buffered saline for
1 h, incubated in the primary antibodies (1:1000) for 1 h, washed in
Tris-buffered saline containing 0.05% Tween 20, and incubated in the
secondary antibodies (1:2000) for another hour. Signals were devel-
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oped by enhanced chemiluminescence (Amersham Biosciences). The
primary antibodies were purchased from Upstate Biotechnologies
(EF-1), BD Pharmingen (NMDA receptor subunit 1 clone 54.1), and
Santa Cruz Biotechnology (sorting nexin 3). Anti PSD-95 was a gift
from Dr. T. Su¨dhof. The anti-ribosome serum was obtained from a
patient with systemic Lupus erythematosus. All secondary antibodies
were purchased from Dako.
Mass Spectrometry of Trypsin-digested Protein Spots from Two-di-
mensional Gels—The mass spectrometer utilized for the high through-
put protein analysis was an Applied Biosystems 4700 Proteomics Ana-
lyzer with TOF/TOFTM Optics. This MALDI tandem mass spectrometer
uses a 200 Hz frequency-tripled neodinium YAG laser operating at a
wavelength of 355 nm. For MS/MS, ions generated by the MALDI
process were accelerated at 8 kV through a grid at 6.7 kV into a short,
linear, field-free drift region. In this region the ions passed through a
timed-ion selector (TIS) device that is able to select one peptide from a
mixture of peptides at different m/z for subsequent fragmentation in the
collision cell. After a peptide at a given m/z was selected by the TIS it
passed through a retarding lens where the ions were decelerated and
then passed into the collision cell, which was operated at 7 kV. The
collision energy was defined by the potential difference between the
source and the collision cell and hence was 1 kV. Inside the collision cell
the selected peptide ions collided with air at a pressure of 1 106 Torr.
After passing through the collision cell the ions (both intact peptide ion,
the precursor, and fragments caused by collision with the air, the
product ions) were reaccelerated in the second source region at 15 kV,
passed through a second, field free, linear drift region, into the reflector
and finally to the detector. The detector amplified and converted the
signal to electrical current, which was observed and manipulated on a
PC-based operating system. For reflector mode the operation of the
instrument is far simpler. After the MALDI process generates the
peptide ions they are accelerated at 20 kV through a grid at 14 kV into
the first, short, linear, field-free drift region. After this point the rest of
the instrument can be treated as a continuation of this field-free, drift
region until the ions enter the reflector and then reach the detector
where, as before, the signal at the detector is amplified and converted to
electrical current. Both MS and MS/MS spectra were searched against
the Mascot data base search engine (Matrix Science) to identify the
proteins.
Electrospray (tandem) mass spectrometric experiments were per-
formed on a Micromass Q-TOF mass spectrometer as described previ-
ously (26). The tryptic-digested samples were loaded into a nanoelec-
trospray capillary, which was pulled from a borosilicate glass capillary
GC 100F-10 with a microcapillary puller. An internal wire electrode
inserted inside the capillary was used for the measurement. The cone
voltage was set at 25–30 V. For MS measurements, the quadrupole was
operated in the rf-only mode and mass analysis was performed using
the TOF analyzer. For tandem MS experiments, precursor ions were
selected using the quadrupole, fragmented in the collision chamber
using energies between 20 and 65 eV and argon as the collision gas, and
the daughter ions detected by the TOF analyzer. Two major tryptic
peptides were used for tandem MS, and the resulting daughter ion
spectra were searched using the Mascot search engine. The electro-
spray MS that we used is less sensitive than the MALDI TOF/TOF®
MS, and the potential co-migrating minor proteins in the protein spots
are less likely to be detected.
ICAT Labeling and Liquid Chromatography-Tandem Mass Spec-
trometry—The PSD fraction of about 0.1 mg was dissolved in 200 l of
0.5% SDS in 50 mM Tris buffer, pH 7.5. It was then diluted 2 times in
50 mM Tris buffer, incubated with 1 mM TCEP, and labeled with ICAT®
reagents according to the instruction of the ICAT labeling procedure as
provided by the company (Applied Biosystems) with minor variations.
Briefly, after neutralization of the ICAT® reagents, the samples were
further diluted to a final concentration of 0.05% SDS. Trypsin at a ratio
of 1:10 with respect to the sample protein concentration was added and
incubated overnight at 37 °C. The digest was acidified and loaded into
a 4 15 mm cation exchange column equilibrated with 10 mM KH2PO4/
25% acetonitrile, pH 3.0 at a flow rate of 1 ml/min. The column was
washed with 3 column volumes of equilibration buffer to remove excess
ICAT and other reagents and bound peptides were eluted from the
column with 400 mM KCl in the same buffer and collected as single
fraction. The fraction was neutralized and loaded into a 4  15 mm
avidin column equilibrated in 2 phosphate-buffered saline. Non-
ICAT-labeled peptides were removed by extensive washing with 2
phosphate-buffered saline, followed by washing with phosphate-buff-
ered saline, 50 mM ammonium bicarbonate/20% methanol, pH 8.3 and
water, and finally the bound ICAT-labeled peptides were eluted with 3
column volumes of 30% acetonitrile/0.4% trifluoroacetic acid. The
eluted peptides were evaporated to dryness and reconstituted in 100 l
of cleavage reagent for 2 h at 37 °C to cleave the biotin portion of the tag
from the labeled peptides. The fraction was dried, reconstituted in 150
l of 5% acetonitrile/0.1% trifluoroacetic acid, and injected into a re-
versed phase capillary trap column at 40 l/min. The peptides were
resolved on a Dionex 75 m 15 cm C18 capillary column at 200 nl/min
using a linear acetonitrile gradient from 5 to 50% in 60 min. The
peptides were sprayed online into an electrospray quadrupole time-of-
flight hybrid MS (QSTAR® from Applied Biosystems). Proteins were
identified by analysis of collected MS/MS data using Pro ICAT™ soft-
ware (Applied Biosystems).
RESULTS
For two decades the 2 Triton extraction method to yield the
PSD fraction from rat brain as developed by Carlin and co-
workers (19, 24) has been the standard protocol for the purifi-
cation of PSD proteins and has been used in previous studies as
the source for the characterization of novel PSD protein com-
ponents. In the present study two independent proteome ap-
proaches were used, namely two-dimensional gel electrophore-
sis in conjunction with MALDI tandem mass spectrometry, and
the ICAT peptide derivatization technique with nano-liquid
chromatography coupled online to electrospray tandem mass
spectrometry.
In the first instance we used the two-dimensional gel-based
method for the isolation of the PSD proteins. We verified the
purification efficacy of the protocol resulting in the PSD frac-
tion. We then completed the characterization of the proteins
from the PSD fraction.
First, we examined the enrichment of well-established PSD
proteins in the PSD fraction, namely an NMDA receptor
subunit NR1 and SAP90/PSD-95, and the depletion of a pre-
synaptic marker protein, the integral synaptic vesicle mem-
brane protein synaptophysin. Equal amounts of P2, synapto-
some, synaptic membrane, and PSD fractions were run on an
SDS gel, electroblotted onto nitrocellulose membranes and
immunostained with antibodies against NR 1, SAP90/PSD-
95, and synaptophysin, respectively. Fig. 1 reveals the high
enrichment of the NR1 and SAP90/PSD-95 in the PSD frac-
tion. Synaptophysin is enriched in the synaptosome, dimin-
ished in the synaptic membrane and totally absent from the
PSD fraction.
Second, the progress of purification was monitored by two-
dimensional gel electrophoresis. 400-g protein extracts of syn-
aptosome, synaptic membrane, and the PSD fractions were
separated by large format two-dimensional gels and stained
with silver. The synaptosome fraction contains a high number
of protein species over a wide range of isoelectric focusing point
(pI) and Mr (Fig. 2A). The PSD fraction on the other hand
exhibits a less complex protein pattern (Fig. 2C). Compared
with the synaptic membrane a number of protein spots are
relatively reduced in the PSD fraction, indicating that these
FIG. 1. Immunoblots of NMDA receptor subunit 1, synaptophy-
sin, and SAP90/PSD-95 from different cellular compartments.
Crude membrane pellet (P2), synaptosome (SynT), synaptic membrane
(SynM), and PSD fraction (PSD) were dissolved in lysis buffer, mixed
with 2 SDS buffer, and 10 g each were resolved in a 10% SDS gel.
After electroblotting to nitrocellulose membranes, the proteins were
visualized using antibodies against NMDA receptor subunit 1 (NR1),
synaptophysin (SynPhy), and SAP90/PSD-95 (PSD-95), respectively.
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proteins may not anchor to the PSD core (Fig. 2B). We then
characterized nine of these proteins spots that are highly ex-
pressed in the synaptic membrane but apparently are absent or
greatly reduced in the PSD fraction. Electrospray tandem mass
spectrometry reveals that eight of them are mitochondrial pro-
teins, namely aconitase, dihydrolipoamide succinyltransferase,
ATP synthase  chain, H-ATP synthase subunit d, pyruvate
dehydrogenase, isocitrate dehydrogenase, fumarase, and dihy-
drolipoamide acetyltranstransferase. Furthermore, there is a
single glial cell-specific protein, the voltage-dependent anion-
selective channel protein 1. Six of these proteins are not de-
tectable in the PSD fraction (see Table I), and the other three
proteins appear as minor spots. This shows that the Triton
X-100 extraction step selectively removes proteins that are
known to be exogenous to the PSD. But it also indicates that a
small fraction of highly abundant proteins, notably mitochon-
drial and glial proteins, might survive the detergent extraction
step and a minor fraction of them partitions into the PSD
fraction.
Although the comparison of the protein profiles across the
two-dimensional gels provides information about the probable
enrichment of specific proteins in the PSD fraction, for two
reasons we did not use this as the criterion to select spots for
identification. First, distinct proteins may have similar physi-
cal properties that may co-migrate in the two-dimensional gel,
in which case the apparent “diminished” spots in the PSD
fraction may still contain “genuine” PSD proteins that are
masked by a more abundant non-PSD protein in the synaptic
membrane. Indeed, even some of the protein spots of the less
protein-dense PSD gel contained multiple protein species (see
Table I). Second, the protein profiles of the synaptic membrane
and the PSD fraction have considerable differences in protein
content, which makes the chance of mismatching significant.
Taken together, we opted for the characterization of all pro-
teins of the PSD fraction that were displayed on the two-
dimensional gel.
It is generally known that silver-stained protein spots are
less favorable for subsequent mass spectrometric analysis, and
give considerable lower yield and coverage compared with
those stained with Coomassie Blue. On the other hand, the
detection limit of colloidal Coomassie Blue staining is about
5–10 times higher than silver staining. To compensate for the
lower sensitivity of the Coomassie Blue staining we increased
the loading of PSD proteins to the two-dimensional gel by about
7 times (i.e. 3 mg of protein), which yield a protein profile that
is approximately equal to that of silver stained gel.
All together, 250 protein spots are visible to the bare eye
(Fig. 3). These spots were excised and digested with trypsin.
The trypsin autodigestion fragments at the protonated masses
of 842.510 Da and 221.104 Da, were used as internal standards
for the calibration of the MS spectra. The MS resolution for the
peptides was generally greater than 10,000 full-width half-
maximum, and the mass accuracy better than 10 ppm. For the
data base search the mass tolerance was set at 0.03 Da. The
MS/MS resolution was 3000–6000 full-width half-maximum.
No internal standard was used for calibration and the mass
tolerance was set higher at 0.3 Da although mass error was
expected to be less than 0.1 Da. All the mass spectra were
searched against the NCBI data base, using online mascot
software.
The identification of the proteins is based on several criteria.
The most important criterion is the mascot score of the PMF,
and in most cases the scores are significant. Further, we also
consider the mascot scores of the daughter ion spectra of the
tryptic peptides, and the matching of the identified proteins to
the calculated Mr and pI. Often, single proteins are present as
several protein spots. As such, we are able to (tentatively)
assign the identities of several proteins that have low mascot
scores by taken into account of the fact that the next nearest
spot differs only slightly in pI and probably also contains the
same protein.
Proteins contained in most of the spots are identified (Table
I). The mitochondrial and glial cell-specific proteins are known
to be the contaminants. All other proteins are considered as
potential PSD proteins, unless otherwise stated (Table I).
These proteins are clustered into distinct groups based on their
described functions (Table II) that can be assigned to diverse
physiological activities, including the cytoskeleton and their
interacting proteins for the maintenance and modulation of
synaptic architecture, the proteins involved in sorting and traf-
ficking of membrane proteins, the proteins involved in anaer-
obic energy supply for the acute requirement of energy during
FIG. 2. Typical examples of the protein profiles of the synaptosome (A), the synaptic membrane (B), and the PSD fraction (C),
separated by two-dimensional gel electrophoresis and stained using silver. The circled protein spots in B were chosen for further
characterization by tandem MS because they are highly expressed in synaptic membrane but are greatly diminished in the PSD fraction, indicating
that they may not anchor to the PSD. 1, aconitase; 2, dihydrolipoamide acetyltransferase; 3, dihydrolipoamide succinyltransferase; 4, ATP synthase
 chain; 5, fumarase; 6, isocitrate dehydrogenase; 7, pyruvate dehydrogenase; 8, voltage-dependent anion-selective channel; 9, H-ATP synthase
subunit d.
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intense neuronal activity, the proteasome system for specific
synaptic protein degradation, the chaperone system for correct
protein folding, the local protein synthetic machinery, and the
scaffold and signaling protein complexes. Finally there are also
a number of novel proteins and proteins with described func-
tions that as yet cannot be assigned in the context of PSD
functioning. Nevertheless, these proteins may be of functional
significance. For example, the primary sequence of the hypo-
thetical 18.5 kDa protein (spot number 9, Table I) is highly
conserved between mouse and human suggesting that it may
serve an important function.
Among the proteins of the PSD fraction some of them may be
localized exclusively to the PSD and are therefore highly en-
riched in the PSD with respect to other cellular compartments,
e.g. the NMDA receptors and SAP90/PSD-95. Alternatively,
some proteins may be present in multiple cellular compart-
ments including PSD. In the latter case their enrichment in the
PSD would be less pronounced than for PSD-specific proteins.
To gain better insight into this compartmental localization of
proteins from distinct functional classes, we performed some
initial immunoblot experiments. Three proteins were chosen
based on the assumption that they may also be present in other
compartments than the PSD, namely EF-1, a translational
factor; sorting nexin 3, a protein that is involved in the traf-
ficking of membrane proteins; and ribosomal protein. Interest-
ingly, Fig. 4 reveals that these three proteins are selectively
enriched in the PSD fraction, indicating that they may be
tightly anchored to the PSD core.
Two-dimensional gel electrophoresis-based methodology is a
widely used technique for proteomics studies. However, in our
FIG. 3. Two-dimensional separation of 3 mg of PSD protein stained with colloidal Coomassie Blue. All visible spots were labeled from
1–250, cut out, and tryptic-digested followed by MALDI MS and MS/MS analyses. There are a number of spots that are not visible to the bare eye
but can be detected by increasing the contrast of the computer image. These spots could not be picked manually and therefore were not analyzed
in the present study.
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TABLE I
Mass spectrometric characterization of PSD proteins fractionated by two-dimensional gel electrophoresis
The spot numbers (Spotnr) correspond to the protein spot numbers indicated in Fig. 3. Mass spectra were searched against NCBI database
using mascot software from Matrix Science. For all samples the tryptic peptide mass fingerprints (PMF) were searched, and their scores listed
under direct analysis mascot score PMF. The six most intense peptide peaks from the tryptic peptide fragments of the proteins were
automatically selected for MS/MS analyses, and the mascot scores of the daughter ion spectra are listed under MS/MS. Blank spaces in the
mascot score mean no hit, which are the cases when the mascot scores are low and the measured and the predicted Mr and pI of the proteins
do not agree. Often, a series of spots that differ slightly in pI represent the same proteins. Accordingly, some of the proteins that have a
relatively low score but are positioned within such a series that match the predicted Mr and pI are also listed. Some samples were further
processed with a Ziptip, and their mascot scores are listed under Ziptip mascot score. The mitochondrial and glial cell-specific proteins can be
considered as contaminants and are shown in italics. CDC rel-1AI and peanut (Drosophilia)-like 1 differ at the C-terminus; the last 5 amino
acids in CDC rel-1AI are replaced by another 21 amino acids in peanut (Drosophilia)-like 1. Peanut (Drosophilia)-like 1 is positively identified
since the peptide fragment contained in the C-terminal region is detected from the mass spectrum. In cases where the fragment from the C
terminus was not detected, the proteins are labelled as CDC rel-1AI. Based on the fact that peanut (Drosophilia)-like 1 is slightly bigger than
CDC rel-1AI, spots numbered 70 and 115 most likely contain peanut (Drosophilia)-like 1 whereas spots numbered 69 and 114 CDC rel-1AI. Spots
numbered 130 and 134 contained a protein with PMF and MS/MS data that corresponds to rat neurofilament triplet M protein. The measured Mr
on the two-dimensional gel, however, is about 40 kDa lower than expected. This protein may represent a fragment, as is the case for pig
neurofilament triplet M protein. Full-length rat neurofilament triple M protein is also present, e.g., fraction 233. Glyceraldehyde-3-phosphate
dehydrogenase exists as two groups; a group (numbered 40-44) which corresponds well to the calculated Mr and pI of the protein, and another group
(numbered 28, 228) which has a substantially lower Mr than expected suggesting that these proteins may represent an isoform(s) or a fragment(s)
of the enzyme.
Spotnr Protein name NCBI
Direct analysis
mascot score
Ziptip mascot
score Mass pI
PMF MS/MS PMF MS/MS
1 Peptidylprolyl isomerase A (cyclophilin A) 8394009 86 223 18171 8.34
2 Peptidylprolyl isomerase A (cyclophilin A) 8394009 57 67 18171 8.34
3 Peptidylprolyl isomerase A (cyclophilin A) 8394009 74 18171 8.34
4 RIKEN cDNA 0810011J09 (similar to ubiquitin-conj-enzyme E2) 20341854 96 16570 7.74
5
6 Sorting nexin 3 4507143 118 18840 8.71
7 Cofilin 1, non-muscle 8393101 77 130 18813 8.22
8 Cofilin 1, non-muscle 8393101 69 18813 8.22
9 Similar to SMT3 suppressor of mif two 3 homolog 2 (yeast) 18564783 65 15012 10.03
ISS-homolog to hypothetical 18.5 kDa protein 12837887 38 137 21046 9.46
10 Superoxide dismutase 2 8394331 71 173 24919 8.96
11 Peroxiredoxin 1 16923958 76 43 102 22371 8.27
Superoxide dismutase 2 8394331 52 306 76 24919 8.96
Similar to TOB3 20901979 41 21691 9.27
Enhancer protein 2135068 69 22503 8.39
12 Adenylate kinase 1 13242235 120 266 21741 7.71
13 Neuronal protein 22 18252579 81 172 22817 6.84
14 Superoxide dismutase 2 8394331 62 74 24919 8.96
Cystaine-rich protein 8393206 38 73 21503 8.90
Similar to TOB3 20901979 43 21691 9.27
15 Superoxide dismutase 2 8394331 50 252 77 24919 8.96
16 Superoxide dismutase 2 8394331 37 24919 8.96
17 Hypothetical protein XP088406 18601785 55 22020 8.10
18 Similar to brain-specific protein p25  20909043 98 127 23763 9.46
19 Glutamate oxaloacetate transaminase 2 6980972 50 111 41 85 47875 9.13
Brain 3-Hydroxyacyl-Coa Dehydrogenase 14488727 48 9 27276 8.91
20 Voltage-dependent anion channel 1 6755963 70 171 30883 8.62
21 Triosephosphate isomerase 1 12621074 94 27465 6.45
22 Triosephosphate isomerase 1 12621074 42 121 182 27465 6.45
23 Phosphoglycerate mutase type B subunit 12844989 142 29038 7.07
24 Triosephosphate isomerase 1 12621074 42 27465 6.45
25 Heat shock protein J2 19855061 107 40 26993 6.99
26 4-Nitrophenylphosphatase domain and non-neuronal SNAP25-like protein 6679066 59 33682 9.48
27 Similar to AU RNA-binding protein/enoyl-Coenzyme A hydratase 20072952 126 200 33002 9.57
28 Glyceraldehyde-3-phosphate dehydrogenase 8393418 64 107 36250 8.14
29 RIKEN cDNA 1200007021 20820786 112 190 31652 8.54
Unnamed protein product 21756059 107 27198 8.48
30 Voltage-dependent anion channel 1 6755963 86 308 30883 8.62
31 Voltage-dependent anion channel 1 6755963 103 245 30883 8.62
32 V-ATPase E2 subunit 20799123 90 41 26388 8.44
33 Voltage-dependent anion channel 1 6755963 58 115 30883 8.62
34
35 Voltage-dependent anion channel 1 6755963 58 13 136 462 30883 8.62
36 Voltage-dependent anion channel 2 13786202 98 135 32385 7.44
37 Voltage-dependent anion channel 2 13786202 98 113 32385 7.44
38 Similar to Myeloid leukemia factor 2 20832291 73 84 28389 6.40
Hypothetical protein XP_166785 20559014 44 31499 6.82
39 Malate dehydrogenase (EC 1,1,1,37) precursor 319830 166 436 36157 8.93
40 Glyceraldehyde-3-phosphate dehydrogenase 8393418 92 145 38250 8.14
41 Glyceraldehyde-3-phosphate dehydrogenase 8393418 125 153 36250 8.14
42 Glyceraldehyde-3-phosphate dehydrogenase 8393418 170 36250 8.14
43 Glyceraldehyde-3-phosphate dehydrogenase 8393418 156 112 36250 8.14
44 Glyceraldehyde-3-phosphate dehydrogenase 8393418 54 65 36250 8.14
45
46 Voltage-dependent anion channel 2 6093769 73 32385 7.44
47 LIM and SH3 protein 1 14249130 148 226 165 30462 6.61
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TABLE I—continued
Spotnr Protein name NCBI
Direct analysis
mascot score
Ziptip mascot
score Mass pI
PMF MS/MS PMF MS/MS
48 Glutamate oxaloacetate transaminase 2 6980972 168 248 47875 9.13
49 Glutamate oxaloacetate transaminase 2 8980972 187 341 47875 9.13
50 Glutamate oxaloacetate transaminase 2 6980972 142 171 47875 9.13
51 Aldolase A, fructose-bisphosphate 6978487 269 488 39847 8.31
52 Aldolase A, fructose-bisphosphate 6978487 239 338 39847 8.31
53 Aldolase A, fructose-bisphosphate 6978487 286 343 39847 8.31
54 Aldolase A, fructose-bisphosphate 6978487 178 268 39847 8.31
55 Aldolase C, fructose-bisphosphate 6978489 167 180 39738 6.67
56 Aldolase C, fructose-bisphosphate 6978489 46 39738 6.67
Poly(rC)-binding protein 1 6754994 45 52 38179 6.66
57 Aldo-keto reductase family 1, member A1 13591894 45 36791 6.84
58 Succinate-CoA ligase 16758586 72 35521 9.54
SW1/SNF-related, matrix-associated, actin-dependent regulator of
chromatin
3687440 67 37934 9.02
59 Creatine kinase, ubiquitous mitochondrial 125316 12 47542 8.72
60 Creatine kinase, ubiquitous mitochondrial 125316 54 76 47542 8.72
61 Creatine kinase, ubiquitous mitochondrial 125316 91 83 47542 8.72
62 Creatine kinase, ubiquitous mitochondrial 125316 88 114 47542 8.72
63 Glutamine synthetase (glutamate-ammonia ligase) 8393456 158 209 43209 6.93
64 Glutamine synthetase (glutamate-ammonia ligase) 8393456 158 43209 6.93
65 Similar to elongation factor Tu 20864488 72 131 173 50042 7.65
66 Poly(rC)-binding protein 1; poly(rC)-binding protein 1 6754994 39 22 38179 6.66
67 Poly(rC)-binding protein 1; poly(rC)-binding protein 1 6754994 27 38179 6.66
68 Purine rich element-binding protein A; Pur alpha 6679573 78 44 35056 6.07
69 CDCrel-1Al 19909845 129 127 42615 6.21
70 Peanut (Drosophila)-like 1 16758814 185 91 44540 6.34
71 Synapsin II 9507161 49 141 53076 8.05
72 Synapsin II 9507161 95 214 53076 8.05
73 Synapsin II 9507161 120 116 53076 8.05
74 Synapsin II 9507161 87 22 53076 8.05
Fibrinogen B--chain 529586 54 34574 8.06
75 Synapsin II 9507161 92 300 53076 8.05
76 Glutamate dehydrogenase 6980956 124 85 61943 8.05
Ca2/calmodulin-dependent protein kinase II  6978593 35 54779 6.61
77 Ca2/calmodulin-dependent protein kinase II  6978593 36 54779 6.61
78 Synapsin II 9507161 60 137 53076 8.05
79 Hypothetical protein FLJ10849 21619404 61 147 49787 6.36
Ca2/calmodulin-dependent protein kinase II  6978593 57 23 104 54779 6.61
IP3K 13591973 44 50548 7.64
80 Hypothetical protein FLJ10849 similar to septin 6 21619404 135 44 166 49787 6.36
Ca2/calmodulin-dependent protein kinase II  6978593 41 11 70 54779 6.61
IP3K 13591973 59 50548 7.64
81 Similar to actin-related protein 2/3 13569956 14 16979 6.15
82  B-ras 1 9966809 69 8 21864 6.00
83 Voltage-dependent anion channel 2 13786202 69 32385 7.44
84 Similar to myeloid leukemia factor 2 20832291 65 28 28398 6.40
85 Tropomyosin 1 , brain 112440 70 32613 4.72
86
87 Glutathione transferase 1 12585231 16 95 28064 6.25
88
89 Calmodulin 2 (phosphorylase kinase, ) 4502549 53 94 16987 4.09
90 Ubiquitin carboxyl-terminal hydrolase L1 8394506 55 25204 5.12
91
92 Similar to -tubulin [Mus musculus] 20884391 56 50 19053 5.46
93 Similar to -tubulin 20884391 49 45 51 19053 5.46
94 ISS-homolog to UMP-CMP KINASE (EO 2.7.1.48)-putative 12836302 78 22459 5.68
95
96 Similar to initiation factor 5A (elF-5A) (elF-4D) 20881893 54 35 14218 5.51
97 ATP synthase subunit d 9508411 81 48 18873 6.17
98 Similar to BAG-family molecular chaperone regulator-2 20845162 36 117 23726 6.01
99 Tumor protein D52-like 1; hD53 4507641 45 22620 5.46
100 F-actin capping protein  subunit; Cap Z 4826659 76 38 31063 5.69
101 F-actin capping protein  subunit; Cap Z 4826659 102 31063 5.69
Prohibitin 6679299 90 29875 5.57
102 STIP1 homology and U-box-containing protein 1 9789907 43 35455 5.71
103 Capping protein  2 6671672 63 3 175 21 33166 5.57
104 SNAP25 interacting protein 30 22129759 113 85 139 11 30359 5.88
105 Tubulin  chain 15 92930 86 16 140 50665 4.79
Protein phosphatase 1, catalytic subunit,  isoform 13994195 70 38353 5.94
106 Acidic ribosomal protein PO 11693176 33 72 34509 5.91
107 Serine racemase 7305521 46 36799 5.68
108 Tubulin  chain 15 92930 125 21 50665 4.79
109 SNAP25 interacting protein 30 22129759 59 97 30359 5.88
LIM and SH3 protein 1 14249130 45 30462 6.61
110 Vesl-1L 13928988 117 41422 5.39
111 Regulator of G-protein signaling 19 interacting protein 1 9055336 29 134 36349 5.65
112 Annexin V 999934 43 35879 5.03
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TABLE I—continued
Spotnr Protein name NCBI
Direct analysis
mascot score
Ziptip mascot
score Mass pI
PMF MS/MS PMF MS/MS
113 Purine rich element binding protein A; Pur  6679573 89 128 35056 6.07
114 CDCrel-1A1 19909845 118 175 42615 6.21
115 CDCrel-1A1 19909845 94 42615 6.21
116 Tubulin  chain 15 92930 99 8 103 50665 4.79
117 Tubulin  chain 15 92930 83 58 50665 4.79
118 STIP1 homology; carboxyl terminus of Hsp70-interacting protein 9789907 70 35455 5.71
119 G protein  2 subunit 1730213 11 85 38295 5.47
120 Tubulin  chain 15 92930 108 45 50665 4.79
121 Tubulin  223556 82 40 51054 4.94
122 Tubulin  223556 56 38 51054 4.94
123 Tubulin  223556 66 46 51054 4.94
124 Actin  71620 105 138 125 42338 5.29
125 Succinyl-CoA ligase 21263999 106 27 46765 5.65
126 Actin  71620 82 42338 5.29
127 Tubulin  chain 15 92930 55 50665 4.79
128 Creatine kinase, brain 6978659 63 22 43160 5.33
129 Vesl-1L 13928988 191 90 41422 5.39
130 Neurofilament triplet M protein 128149 111 16 52017 5.15
Creatine kinase, brain 6978659 33 41 43160 5.33
131 Vesl-1L 13928988 234 140 41422 5.39
132 Actin  71620 63 136 42338 5.29
133 Actin  71620 117 217 42338 5.29
134 Neurofilament triplet M protein 128149 109 52017 5.15
135 Vesl-1L 3452560 128 81 41485 5.46
136 Actin  71620 116 379 42338 5.29
137 Actin  71620 161 384 42338 5.29
138 Actin  71620 150 365 42338 5.29
139 Actin  71620 161 379 42338 5.29
140 Neurofilament, light polypeptide 13929098 95 56 61531 4.63
Actin  71620 62 178 42338 5.29
141 e-Tropomodulin 6981658 99 21 40770 4.97
Actin  71620 99 126 42338 5.29
142 Neurofilament, light polypeptide 13929098 41 7 61531 4.63
Vesl-1L 3452560 40 41485 5.46
143 Glial fibrillary acidic protein delta 5030428 206 45 48953 5.72
Vesl-1L 3452560 104 122 41485 5.46
144 Tubulin  chain 15 92930 147 162 50665 4.79
145 Tubulin  chain 15 92930 214 189 50665 4.79
146 Neurofilament, light polypeptide 13929098 293 160 61531 4.63
147 Neurofilament, light polypeptide 13929098 75 34 61531 4.63
148 Neurofilament, light polypeptide 13929098 293 61531 4.63
Proteasome (prosome, macropain) 26S subunit, ATPase 9 13928808 116 50078 5.04
Protein kinase C and casein kinase substrate in neurons 1 (Syndapin) 8393896 107 50952 5.15
Tubulin  chain 15 92930 68 50865 4.79
Glial fibrillary acidic protein 8393431 67 50146 5.35
149 Neurofilament, light polypeptide 13929098 155 39 61531 4.63
150 Tubulin  chain 15 92930 118 46 50665 4.79
151 Glial fibrillary acidic protein  5030428 261 123 48953 5.72
Neurofilament, light polypeptide 13929098 98 52 61531 4.63
152 Tubulin  chain 15 92930 107 132 50665 4.79
153 Tubulin  223556 103 215 51054 4.94
154 Glial fibrillary acidic protein 8393431 393 299 50146 5.35
155 Tubulin  223556 109 215 51054 4.94
156 Tubulin  223556 142 367 51054 4.94
157 Tubulin  223556 82 348 51054 4.94
158 Tubulin  chain 15 92930 148 135 189 50865 4.79
159 Tubulin  223556 69 126 51054 4.94
160 Neurofilament, light polypeptide 13929098 294 158 61531 4.63
161 Internexin,  9506811 260 146 56317 5.20
162 Tubulin  223556 7 71 51054 4.94
Internexin,  55622 81 55776 5.20
163 Tubulin  223556 53 19 51054 4.94
164 Internexin,  9506811 39 56317 5.20
165 Internexin,  9506811 280 80 287 56317 5.20
166 Internexin,  9506811 297 310 56317 5.20
167 Internexin,  9506811 280 56317 5.20
168 Internexin,  9506811 408 259 56317 5.20
169 Internexin,  9506811 360 363 56317 5.20
170 Internexin,  9506811 366 201 56317 5.20
171
172 Hypothetical protein similar to adenylate kinase 5 13874609 66 49572 4.99
173 Heat shock 70kD protein 8; Heat shock cognate protein 70 13242237 145 107 71263 5.37
Neurofilament, light polypeptide 13929098 64 13 61531 4.63
174 Heat shock 70kD protein 8; Heat shock cognate protein 70 13242237 233 71263 5.37
Neurofilament, light polypeptide 13929098 137 61531 4.63
175 Heat shock 70kD protein 8; Heat shock cognate protein 70 13242237 249 407 71263 5.37
176 Heat shock 70kD protein 8; Heat shock cognate protein 70 13242237 109 26 71263 5.37
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TABLE I—continued
Spotnr Protein name NCBI
Direct analysis
mascot score
Ziptip mascot
score Mass pI
PMF MS/MS PMF MS/MS
177 Neurofilament protein, middle polypeptide 8393823 64 90 95885 4.76
178 Synapse-associated protein SAP90 9665227 136 174 80902 5.58
179 Synapse-associated protein SAP90 9665227 181 244 330 80902 5.58
180 Synapse-associated protein SAP90 9665227 227 99 276 80902 5.58
181 Internexin  9506811 202 97 56317 5.20
182 Tubulin  chain 15 92930 130 50665 4.79
183 Tubulin  chain 15 92930 110 106 176 50665 4.79
184 Vimentin 14389299 48 53933 5.06
Tubulin  chain 15 92930 48 11 50665 4.79
185 Internexin,  9506811 216 72 56317 5.20
186 Vimentin 14389299 41 53933 5.06
187 Actin-like 6 13937393 75 41 47573 5.48
188
189 Tubulin  223556 50 51054 4.94
190 Heterogeneous nuclear ribonucleoprotein H 9845253 54 14 49821 5.89
191 Heterogeneous nuclear ribonucleoprotein H 9845253 37 64 49821 5.89
192 Heterogeneous nuclear ribonucleoprotein H 10946928 48 93 49693 5.89
193 Heterogeneous nuclear ribonucleoprotein H 9845253 90 122 49821 5.89
194 Tubulin  chain 15 92930 68 44 50665 4.79
195 Tubulin  chain 15 92930 97 74 50665 4.79
196 Tubulin  223556 76 247 51054 4.94
197
198
199 Unknown protein for MGC 17391508 20 73624 5.96
200 Chaperonin subunit 2 () 57993 62 57993 5.97
Tubulin  chain 15 92930 63 29 50665 4.79
201 Septin 6 14714696 56 24 49324 6.12
202 Tubulin  223556 50 51054 4.94
Similar to Putative serine/threonine-protein kinase P78 20910752 20 53170 5.80
203
204 Synapsin II 6885997 101 268 63974 8.73
205 Synapsin II 6685997 104 96 63974 8.73
206 Synapsin II 6685997 90 307 63974 8.73
207 Synapsin II 6685997 107 186 63974 8.73
208 Synapsin II 6685997 90 285 63974 8.73
209 Synapsin II 6685997 140 188 63974 8.73
210 Synapsin Ib 112348 93 68 70038 9.84
211 Brain-specific angiogenesis inhibitor 1-associated protein 2 (IRSP 53) 17105348 202 57974 8.97
Synapsin Ib 112348 153 320 70038 9.84
212 Synapsin Ib 112348 116 435 70038 9.84
213 Synapsin I 9507159 71 100 74354 9.81
214 Synapsin I 9507159 50 49 74354 9.81
215 Synapsin Ib 112348 62 75 70038 9.84
216 Similar to DnaJ-like protein 20830104 53 60 44949 6.65
217
218 Translationally controlled tumor protein TCTP 20876984 40 147 19552 4.93
219 Similar to Tubulin -2 chain 20822920 28 17 23872 5.49
220
221 Ubiquitin carboxyl-terminal hydrolase L1 8394506 14 25204 5.12
222 Synapse-associated protein SAP90 9665227 157 150 80902 5.58
PSD-95-binding protein 7514059 36 76944 5.56
223 DnaK-type molecular chaperone grp75 precursor 2119726 81 138 73984 5.87
224 Heat shock 70 kDa protein 1 2506541 62 55 70236 5.46
225
226 Synapsin II 6685997 66 275 63974 8.73
227 Synapsin II 6685997 76 287 63974 8.73
228 Glyceraldehyde-3-phosphate dehydrogenase 8393418 47 36250 8.14
229 Spinophilin: neurabin II 16758228 91 28 89706 4.86
Rabaptin 5 9506845 65 27 99366 4.95
230  II spectrin 1495198 275 128 285218 5.19
231  II spectrin 1495198 327 218 285218 5.19
232  II spectrin 1495198 311 17 285218 5.19
233 Neurofilament triplet M protein 482393 38 34 95719 4.78
234 Eukaryotic translation elongation factor 1  2 15805031 74 66 50652 9.10
235 Malate dehydrogenase (EC 1.1.1.37) precursor 319830 39 36157 8.93
236 Synapsin Ib 112348 111 161 70038 9.84
237 Synapsin Ib 112348 61 42 70038 9.84
238 Mitochondrial aconitase 13242312 74 54 86354 7.87
239
240 Alpha II spectrin 1495198 99 285218 5.19
241 Eukaryotic translation initiation factor 4E 6681293 10 25037 5.79
242
243  tubulin expressed seq. 19527242 20 51069 5.66
244 F-actin capping protein  subunit; Cap Z 4826659 28 18 31063 5.69
245 78 KDa glucose-regulated protein grp 78 121574 85 101 72633 5.07
246 Synapse-associated protein SAP90 9665227 71 47 80758 5.58
247 Synapse-associated protein SAP90 9665227 102 95 80758 5.58
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study some major PSD proteins are under-represented, for
example, glutamate receptor subunits are not detected al-
though they are known to be highly enriched in the PSD frac-
tion. To address this problem we performed an independent
experiment, using the newly developed method that combines
the ICAT derivatization/purification protocol of the trypsin-
digested PSD to nanoliquid chromatography-electrospray tan-
dem mass spectrometry (27–29).
Briefly, the purified sample is labeled with the ICAT® rea-
gent and then digested with trypsin to produce tryptic peptides.
The ICAT® reagent consists of three basic moieties; a biotin
tag, a variable linker region (12C or 13C-labeled that is used if
two similar samples are to be analyzed to discover their rela-
tive differences in terms of protein expression, one labeled with
the 12C version the other with the 13C) and a cysteine reactive
portion. Thus, derivatization with the ICAT® reagent gener-
ates cysteine-containing peptides that can be affinity selected
from non-derivatized peptides using avidin chromatography,
substantially reducing sample complexity. These derivatized
peptides can then be analyzed by LC-MS/MS, producing daugh-
ter ion spectra by collision-induced dissociation that can be
analyzed by data base searching to reveal the identity of the
protein from which they were digested. If two similar samples
are to be analyzed (e.g. control and treated) relative changes in
protein expression can be inferred from relative differences in
intensity of the 12C and 13C-labeled (but otherwise identical)
peptides. However, the purpose of experiments described here
was identification rather than relative quantitation.
Thus, after elution from the avidin affinity column, the cys-
teine-containing peptides were resolved by reversed phase liq-
uid chromatography and sprayed online into an electrospray
tandem mass spectrometer. Peptides were selected automati-
cally in a data-dependent manner and fragmented in a collision
cell. Two independent experiments have been performed. In
the first ICAT experiment a total of about 1200 MS/MS spectra
were generated. The spectra were searched against the Pro
ICAT™ engine. Approximately 850 MS/MS spectra gave pro-
tein hits, of which 356 of the putatively identified proteins have
a score of 10 or above. In the second ICAT experiment 202
putatively identified proteins have a score of at least 10. While
the two-dimensional gel electrophoresis type experiment has
several criteria to assist the assignment of the protein identi-
fications, such as PMF, MS/MS data, pI and Mr of the protein
spots, LC-MS/MS experiments rely solely on the MS/MS spec-
tra for the protein identification, and therefore may be prone to
the generation of false positive results. To filter off false posi-
tive results we firstly excluded any protein identifications other
than those from rat. The data from the two ICAT experiments
were pooled together for the analysis. When two distinct pep-
tides from different MS/MS spectra with scores above 10 can be
matched to a single protein, it is considered as significant. For
proteins that are matched by single peptides a more stringent
criterion is applied; the confidence must be at least 70 and the
score at least 20. In total 61 proteins are identified after the
application of these stringent conditions (Table III). We believe
that we have excluded all the false positive results. Further-
more, the identified proteins, especially those detected with
multiple peptides, are most likely the abundant proteins of the
PSD fraction. Proteins of lower abundance generally gave
lower quality mass spectra or may be detected but not selected
for MS/MS analysis. Therefore, it is inevitable that there are a
number of false negative results. For example, proteins that
are known or expected to be present in the PSD such as dy-
namin, parkin, 14-3-3 protein, cadherin, Epac, and MAGI-3
etc., are detected at lower confidence and/or score and are not
listed in Table III. Thus, in summary Table III represents
proteins that have been confidently identified using an ICAT
LC-MS/MS approach.
In addition to the cytosolic proteins and cytoskeletal pro-
teins, the LC-MS/MS experiment allows the detection of mem-
brane proteins such as the ionotropic glutamate receptors and
ion channels, large proteins (plectin  500 kDa) and basic
proteins (ribosomal protein  pH 10) that were not detected by
the two-dimensional gel approach (Table II). Some of the pro-
teins identified here have been previously reported to be pres-
ent in PSD, e.g. band 83 (PMES-; Ref. 30) and Esau, but their
functions are currently unknown and are not listed in Table II.
In short, the ICAT LC-MS/MS and the two-dimensional gel MS
and MS/MS experiments are complementary.
DISCUSSION
The PSD is considered to be a tightly packed protein complex
containing receptors and ion channels that are anchored and
clustered by scaffold proteins. There are a number of signaling
proteins that regulate the intrinsic properties of the receptors,
and that may modulate their trafficking via the actions of the
cytoskeletal proteins (9–10).
Our proteome study indicates that the PSD has a high pro-
tein complexity and also indicates novel aspects of functional-
ity. Broadly, we can distinguish two salient features of the PSD
proteins. First, two-dimensional gel experiments reveal that
many distinct proteins are detected as multiple protein spots,
suggesting that they exist as isoforms or are post-translation-
ally modified. Phosphorylation and to a lesser extent palmitoy-
lation and nitrosylation of a number of PSD proteins have been
implicated in the regulation of the proteins’ intrinsic properties
and/or their trafficking and localization, and play important
roles in the induction and expression of synaptic plasticity
(31–33). Second, the PSD contains distinct functional groups of
proteins that might be involved in diverse physiological activ-
ities of the PSD. The groups include proteins of the cytoskele-
ton and their interaction partners for the maintenance and
modulation of synaptic architecture; proteins involved in sort-
ing and trafficking of membrane proteins; components for the
anaerobic energy supply for the acute requirement of energy
during intense neuronal activity; the proteasome system for
specific synaptic protein degradation; the chaperone system for
correct protein folding; the local protein synthetic machinery;
the scaffold and signaling protein complexes and of course the
receptors, ion channels and adhesion molecules. There are also
a number of proteins with unknown function, and proteins that
currently are not known to fall into one of the above-mentioned
functional categories. The interpretation of their physiological
significance in PSD functioning is not clear at the moment, and
TABLE I—continued
Spotnr Protein name NCBI
Direct analysis
mascot score
Ziptip mascot
score Mass pI
PMF MS/MS PMF MS/MS
248 Synapsin Ib 112348 52 71 70038 9.84
249 Brain-specific angiogenesis inhibitor 1-associated Protein 2 (IRSP 53) 17105348 67 57974 8.97
Calmodulin-dependent protein kinase II  6978593 48 112 54081 6.61
250 Brain-specific angiogenesis inhibitor 1-associated protein 2 (IRSP 53) 17105348 74 57974 8.97
Calmodulin-dependent protein kinase II  6978593 35 76 54081 6.61
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therefore these proteins are not further discussed in the pres-
ent study.
The Scaffold and Adaptor Proteins—The scaffold and adap-
tor proteins in the PSD regulate the assembly and function of
the complex macromolecular protein network. They cluster
diverse receptors/ion channels, signaling proteins and adhesion
molecules in the PSD, and link them further to the cytoskeletal
proteins (9–11, 33–34). In accordance to previous studies the
immunoblot experiment reveals the enrichment of SAP90/
PSD-95 in PSD. Interestingly, the two-dimensional gel displays
6 forms of SAP90/PSD-95, 6 forms of vesl-1L/homer and a
single PSD-95-binding protein (GKAP/SAPAP1). The chemical
diversity of these single proteins suggests the existence of
multiple post-translationally modified forms. Indeed, the effect
of a series of phosphorylation events of a protein is the gener-
ation of a train of spots in the two-dimensional gel that differ
significantly in their pI and moderately in their Mr. In case of
SAP90/PSD-95, there are in addition isoforms that differ in
both pI and Mr suggesting that changes such as palmitoylation
and/or expression of alternatively spliced forms may occur.
Such high degree of diversity of single scaffold proteins has not
been previously reported, and this demonstrates the usefulness
of a proteome approach displaying the global PSD protein
content. The different (post-translationally modified) forms of
individual proteins may imbue them with an enhanced poten-
tial for differential interactions with various partners (35) po-
tentially in an activity dependent manner. Although the ICAT
LC-MS/MS experiment could not detect the presence of various
SAP90/PSD-95 isoforms, it does identify extra scaffold proteins
including chapsyn-110, densin-180, maguin, SAP 97, shank,
and SAP 102, all of which have been previously reported to be
PSD proteins.
The Signaling Proteins—The activity-dependent interaction
of the various signaling pathways in the dendritic spine is
considered as the basis of neuroplasticity. Accordingly, en-
zymes involved in these pathways are detected in our PSD
preparation. It has been demonstrated that CaMKII is the
major protein constituent of the PSD fraction (18). In the pres-
ent study CaMKII is detected as 6 distinct spots that differ
slightly in Mr and/or pI, suggesting that they may be differen-
tially post-translationally modified. Indeed, differential phos-
phorylation of CaMKII is considered to be a key factor in the
trafficking and functioning of this protein (36). In contrast to
CaMKII, only a single form of calmodulin is detected. Further,
a number of enzymes from other signaling pathways are pres-
ent in the PSD fraction, such as the cyclic nucleotide-dependent
signaling pathway including protein phosphatase, PKA, and
phosphodiesterase 11A2 that catalyze the hydrolysis of both
cAMP and cGMP (37); the phosphoinositide pathway including
IP 3-kinase and PKC; the G protein-coupled receptor pathway
including the G protein, regulator of G protein signaling 8, and
GIPC which is a single PDZ domain containing protein that has
been proposed to regulate G protein signaling (38). Neurofibro-
min is a ras GTPase-activating protein, which function as
negative regulator of Ras. This protein is involved in the pro-
cesses of neuronal development (39) and learning (40). SynGAP
is another ras GTPase-activating protein that interacts with
SAP90/PSD-95, and may regulate the MAP kinase pathway
within the dendritic spine. Recent studies indicate that this
protein modulates neuronal development, regulates glutamate
receptor synaptic targeting, and is involved in the induction of
LTP (41–42). Citron also interacts with SAP90/PSD-95 (43),
and functions as Rho/Rac effector protein involved in the orga-
nization of the cytoskeleton (44). Wnt signaling pathway, which
may be involved in the synaptic modeling and pre- and postsyn-
aptic differentiation (45), possible exists in the PSD because we
detect the Wnt inhibitor factor 1, which negatively regulates
Wnt signaling (46). B-ras 1 is known to interact with NF-
and I-B and regulates their activity. Both NF- and I-B have
previously been detected as PSD proteins (47), and are impli-
cated as molecules that mediate signaling to the cell body and
modulate gene expression. Other signaling proteins are known
to occur at a much lower level than for instance CaMKII in the
PSD fraction, and some of them may also exist only in a
subpopulation of the synapses. For example, nitric-oxide syn-
thase was shown to be present in less than 10% of the synapses
(48). Probably due to their low abundance, these proteins re-
main undetected in our study.
The Cytoskeletal and Their Interacting Proteins—The archi-
tectures of the PSD and the dendritic spines are maintained by a
number of cytoskeletal proteins. In agreement with previous
studies (18) we have identified a variety of these proteins, includ-
ing actin, tubulin, plectin, internexin, neurofilament, spectrin,
myosin, microtubule-associated protein, and tropomyosin.
Several cytoskeletal proteins are highly abundant in the
PSD fraction, and they form a cytoskeletal matrix in the spine
that gives the characteristic electron dense appearance of the
PSD (21). Frequently, single protein species are detected as
multiple protein spots on the two-dimensional gel, suggesting
that isoforms or post-translational modifications of the proteins
occur. In this respect, phosphorylation of cytoskeletal proteins
(as driven by the changes in signal transduction events) plays
an important role in their polymerization/depolymerization
and the activity-dependent modulation of the cytoskeletal ma-
trix (49–50).
The PSD and synaptic spines are not static; changes in
neuronal activity can bring about rapid alteration of the size
and morphology of these structures, which in turn may change
the synaptic efficacy (51–52). Of particular interest is a recent
study that demonstrated that 85% of actin in the spine is
dynamic, with a turnover rate of 44 s (53). As actin microfila-
ments are associated with structural plasticity, the identifica-
tion of a number of actin-regulatory proteins in the present
study is entirely consistent with the idea of rapid structural
changes driven by reorganization of the actin-microfilament in
the spine. These proteins include cofilin, which depolymerizes
actin filaments from its pointed end thereby increasing actin
dynamics (54); F-actin capping protein Z and capping protein
2, which bind to the barbed end of actin filaments (54);
neurabin 2, which binds to actin and recruits protein phospha-
tase to actin that controls actin rearrangement (55); the LIM
and SH3 domain-containing protein, which is proposed to play
important roles in the regulation of dynamic actin-based, cy-
toskeletal activities (56). Another LIM domain containing pro-
tein present in the PSD fraction, the cysteine rich protein, has
been shown to interact with the actin cytoskeleton and may be
involved in muscle differentiation (57). Tropomodulin lowers
the apparent affinity of pointed ends of the actin filament for
actin monomers (58). Syndapin regulates endocytosis and actin
dynamics (59). Chaperonin containing tail-less complex
polypeptide 1 is known to assist folding of actin and tubulin
(60). Insulin receptor tyrosine kinase substrate p58/53 inter-
acts with the ProSAP/Shank scaffolding proteins of the PSD
(61); in addition to its function as a substrate of insulin receptor
signaling this protein is also known to regulate cytosketelal
dynamics (62). Actin related protein 2/3 (54, 62), and related
members together form the actin nucleation center for the
polymerization of actin. Insulin receptor tyrosine kinase sub-
strate p58/53 together with the members of Wiskott-Aldrich
syndrome protein family are also involved in this process (62).
In addition, we have identified some cytoskeletal protein-inter-
acting proteins such as the neuronal protein 22, and the trans-
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TABLE II
Functional clustering of the identified proteins
Novel proteins and proteins with described functions that cannot be grouped as below are not shown. Many proteins are detected as multiple
spots on the two-dimensional gel, strongly suggesting the presence of post-translational modifications of the proteins and/or the expression of
isoforms. Proteins identified from the ICAT experiment alone do not contain a spot number.
Protein name Spot number
Scaffold proteins
SAP90/PSD-95 178; 179; 180; 222; 246; 247
Vesl-1L/Homer 1 110; 129; 131; 135; 142; 143
PSD-95-binding protein (GKAP/SAPAP1) 222
Chapsyn-110/PSD93
SAP102
SAP97
Maguin
Shank-1
Densin-180
Signaling proteins
CaMKII,  76; 77; 79; 80; 249; 250
IP3 kinase 79; 80
Protein phosphatase 1 105
 B-ras 1 82
Calmodulin 89
Ser/Thr protein kinase P78 202
G protein  2 subunit 119
RGS 19-interacting protein 1/GIPC 111
Regulator of G protein signalling 8
cAMP-dependent protein kinase
Phosphodiesterase 11A2
Citron
SynGAP-a
CaMKII, , , 
Neurofibromatosis type 1
Wnt inhibition factor 1
Protein kinase C 
Cytoskeletal and their interacting proteins
Actin,  124; 126; 132; 133; 136–141
Actin-like 187
Tubulin,  121–123; 153; 155–157; 159; 162; 163; 189; 196; 202
Tubulin,  105; 108; 116; 117; 120; 127; 144; 145; 148; 150; 152; 158; 182–184
194; 195; 200
Tubulin,  243
Internexin,  161; 162; 164–170; 181; 185
Neurofilament, light polypeptide 140; 142; 146–149; 151; 160; 173; 174
Neurofilament, middle polypeptide 177
Neurofilament, triplet M protein 130; 134; 233
Spectrin,  II 230–232; 240
Tropomyosin 85
Annexin V 112
Cofilin 7; 8
F-actin-capping protein 100; 101; 244
Capping protein  2 103
Neurabin 2/Spinophilin 229
LIM and SH3 protein 1/Lasp-1 47; 109
Cysteine-rich protein 1 14
Tropomodulin 141
Syndapin-1 148
Chaperonin-containing TCP1 200
Insulin receptor substrate protein 53/IRSP 53 211; 249; 250
Actin-related protein 2/3 81
Neuronal protein 22 13
TCTP 218
Microtubule-associated protein
Myosin Va
Drebrin
Plectin
Proteins involved in Trafficking
Sorting nexin 3 6
CDCrel-1 69; 114; 115
Septin-6 79; 80; 201
Peanut (Drosophilia)-like 1 70
Rabaptin-5 229
TOB-3 11; 14
N-ethylmaleimide-sensitive factor
Chaperones
Heat shock protein J2 25
Hsc-70 173–176
Hsp-70 224
Bag-2 98
C terminus of Hsp70-interacting protein (CHIP) 118
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lationally controlled tumor protein. Annexin is shown to inter-
act with actin. This calcium and phospholipid binding protein
probably participates in membrane (re)organization and vesi-
cle trafficking (63). Drebrin is a major actin-binding protein in
the brain. Recently, it is reported that this protein is involved
in the synaptic targeting of PSD-95 (64).
Proteins Involved in Trafficking—Various proteins travel
into and out of the PSD, often in a neuronal activity-dependent
manner. The alteration of the PSD protein content, for example
the insertion or removal of glutamate receptors and SAP90/
PSD-95, can modulate synaptic efficacy. Several proteins that
are known to regulate vesicle trafficking are identified in the
PSD preparation. For instance, sorting nexin 3 may interact
with membrane receptors and target these to endosomes and/or
recycle them back to the plasma membrane (65). Immunoblot-
ting reveals that this protein is enriched in the PSD fraction.
Two factors may underlie this enrichment; sorting nexin 3 may
be embedded in the core structure of PSD or it may exist in the
membranes of endosomes within the synaptic spine and are
linked to PSD via cytoskeletal proteins.
CDCrel-1, peanut (Drosophila)-like 1, septin 6 and a hypo-
thetical protein similar to septin, are GTPases that belong to
the septin/CDC family. They may interact with actin, and may
also self-assemble into a filament structure. They are impli-
cated in the trafficking of vesicles and organizing proteins at
the plasma membrane of a neuron (66). Previously, a septin
(CDC 10) has been identified in a PSD fraction, and has been
shown to be slightly enriched in the PSD (18). Rabaptin 5 forms
a complex with other proteins such as Rab 5 that together
regulate the trafficking of vesicles between the plasma mem-
brane and an early endosome (67–68).
In the dendritic spine N-ethylmaleimide-sensitive factor
maintains synaptic AMPA receptor response via the recycling
of the receptors to the PSD and/or stabilizing AMPA receptors
in the PSD membrane (69).
The Chaperones—Heat shock protein (Hsp) 70 kDa family
molecular chaperones play critical roles in protein folding and
trafficking. Previous studies revealed the presence of Hsc 70
and Hsp 40 in the PSD fraction (12, 18, 70). Similarly, we
detect Hsc 70 and Hsp 40 in the PSD fraction. The heat shock
proteins form a complex that is used for folding and conforma-
tional regulation of a variety of proteins, including receptors
and signal transduction regulators.
In addition, two co-factors of the chaperones are identified,
namely BAG-2 and C terminus of HSP 70 interaction protein
(CHIP). BAG-2 may bind to the ATPase domain of Hsc 70, and
inhibits the chaperone activity (71). Members of the BAG fam-
ily were also shown to interact with other proteins, suggesting
that they may operate as bridging molecules that recruit mo-
FIG. 4. Immunoblots of representative proteins belonging to
distinct functional groups from different cellular compart-
ments. Crude membrane fraction (P2), synaptosome (SynT), synaptic
membrane (SynM), and PSD fraction were dissolved in lysis buffer,
mixed with equal volume of 2 SDS buffer, and 10 g each were
resolved on a 10% SDS gel. After electroblotting to nitrocellulose mem-
branes, the proteins were detected by an antibody against sorting
nexin-3 (SortNx), serum of a patient with autoimmune disease against
ribosomal proteins (Ribosomal) and an antibody against elongation
factor 1 (EF -1).
TABLE II—continued
Protein name Spot number
Local synaptic protein synthetic machinery
Acidic ribosomal protein P0 106
Heterogeneous nuclear ribonucleoprotein H 190–193
Poly(rC)-binding protein 1 56; 66; 67
Purine rich element-binding protein A 68; 113
Enoyl-coenzyme A hydratase 27
Translation elongation factor 1  2 234
Initiation factor 5A 96
Translation initiation factor 4E 241
40 S ribosomal protein S24
Energy production/transfer systems
Glyceraldehyde-3-phosphate dehydrogenase 28; 40–44; 228
Triosephosphate isomerase 1 21; 22; 24
Phosphoglycerate mutase type B 23
Aldolase, fructose-bisphosphate 51–56
Creatine kinase, brain 128; 130
Adenylate kinase 1 12
Adenylate kinase 5 172
Ubiquitination system
Ubiquitin-conjugating enzyme E2 4
Proteasome 26 S subunit, ATPase 3 148
Ubiquitin carboxyl-terminal hydrolase L1 90; 221
Pre-synaptic proteins
Synapsin I 210–215; 236; 237; 248
Synapsin II 71–75; 78; 204–209; 226; 227
SNAP25-interacting protein 30 104; 109
Rabphilin 3A
Bassoon
Receptors, Ion channel, and adhesion molecules
NMDA receptor 2A
NMDA receptor 2B
NMDA receptor 1
AMPA receptor B
Voltage-gated sodium channel
Calcium channel isoform
Brevican
Neurofascin
Plakoglobin
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lecular chaperones to target proteins, presumably thereby
modulating protein functions through alteration of the
conformation.
CHIP decreases net ATPase activity of the chaperone and
reduces their efficiency. This implicates CHIP in the negative
regulation of the forward reaction of the Hsc70-Hsp70 sub-
strate-binding cycle (72). CHIP also displays E3 ubiquitin li-
gase activity mediated by its U-box domain. CHIP can interact
with BAG-1, and both proteins may be involved in the ubiquiti-
nation and proteasome-mediated degradation of proteins (73),
including several membrane-bound receptors as well as Hsc 70,
in a chaperone-dependent manner.
The Local Synaptic Protein Synthetic Machinery—Ribosomal
proteins, and proteins that are involved in different stages of
TABLE III
Identified PSD proteins by ICAT nano-liquid chromatography tandem mass spectrometry
The tandem mass spectra were searched against the NCBI database, using the Pro ICAT program. Proteins shown are present in the rat
database. For those that are matched with two or more peptides, the minimum score is 10. For proteins identified with a single peptide the
minimum confidence and score are set to 70 and 20, respectively. Number (Nr) refers to the number of peptides that are matched to a protein. For
proteins that are matched with two or more peptides, the score and confidence of the highest value from a single peptide are shown. For database
search one missed cleavage is allowed. In cases where the actual digested peptide and an extended partial with a missed cleavage are present, they
are counted as distinct peptides.
Accession no. Name Nr Confidence Score
gi294527 2,3-Cyclic nucleotide 3-phosphodiesterase 7 99 36
gi11120682 Ca2/calmodulin-dependent protein kinase II  chain 5 99 44
gi10122138 SynGAP-a 4 99 49
gi1095318 SAP 97 4 99 40
gi57429 -Tubulin T  15 4 99 34
gi20879869 Densin-180 4 99 32
gi204402 Glutamine synthetase 4 99 28
gi1864087 SAPAP1 4 90 34
gi27732033 Creatine kinase, mitochondrial 3 99 48
gi6978593 Ca2/calmodulin-dependent protein kinase II  chain 3 99 42
gi206455 PSD-95/SAP 90 3 99 39
gi27713216 Tubulin  3 99 35
gi1561642 Plectin 3 99 27
gi6980984 Glutamate receptor, NMDA2B 3 99 21
gi5081657 N-Ethylmaleimide sensitive factor 3 90 29
gi27664478 Fructose-bisphosphate aldolase A 3 90 27
gi125289 Ca2/calmodulin-dependent protein kinase II  subunit 3 75 26
gi350611 Transaminase, Glu oxaloacetic 3 75 26
gi2745840 Postsynaptic density protein: citron 3 70 20
gi56198 Glutamate dehydrogenase 3 50 21
gi8393206 Cysteine-rich protein 3 50 18
gi1142640  actinin 2 99 42
gi56699 Rat brain myelin phospholipid 2 99 37
gi205509 Myelin/oligodendrocyte glycoprotein 2 99 35
gi461475 ADP,ATP carrier protein 2 99 31
gi21245098 Tubulin,  3 2 99 29
gi11560113 Chapsyn-110 2 99 25
gi6978595 Ca2/calmodulin-dependent protein kinase II delta chain 2 90 33
gi66727 Protein kinase C  2 90 20
gi6981264 Neurofibromatosis type 1 2 75 20
gi509397 Aggrecan-like protein/ brevican 2 70 14
gi2155310 Glutamate receptor, NMDA2A 2 50 18
gi13591886 Microtubule-associated protein 2 50 17
gi9506427 Bassoon 2 50 16
gi533711 Rabphilin-3A 2 50 14
gi14029139 Wnt inhibitor factor 1 2 40 18
gi3087876 Voltage-gated sodium channel variant 2 40 17
gi27683621 Similar to actin  2 40 16
gi27731499 Similar to Zinc finger protein 208 2 30 18
gi204382 Glutamate receptor subunit 2 (GluR-b) 2 25 12
gi13431673 Myosin Va 2 10 14
gi1346129 Glial fibrillary acidic protein 2 10 16
gi14578563 Calcium channel isoform  1E7 2 10 11
gi27684483 Similar to class I -tubulin 2 10 12
gi204964 -Internexin 1 99 40
gi4761595 Shank 1a 1 99 38
gi23592555 Glyceraldehyde-3-phosphate dehydrogenase 1 99 25
gi13489065 Maguin-2; maguin-1 1 95 22
gi21728392 Band 83 1 95 21
gi1842427 Neurofascin 1 90 36
gi9507161 Synapsin 2 1 90 31
gi27717199 Protein kinase, cAMP-dependent regulatory, type II  1 90 21
gi1497985 Plakoglobin 1 75 26
gi3452560 Vesl-1L 1 75 23
gi2498314 Drebrin A 1 75 23
gi27733035 40 S ribosomal protein S24 1 70 28
gi236953 SAP 102 1 70 24
gi6093964 Regulator of G protein signaling 8 1 70 24
gi508971 NMDAR1 glutamate receptor subunit 1 70 21
gi18143349 Phosphodiesterase 11A2 1 70 20
gi19705475 Esau 1 70 20
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translation process, were identified. The presence of these pro-
teins in the PSD agrees with current studies on long term
neuroplasticity demonstrating the requirement of the activity-
dependent de novo protein synthesis in the synapses for the
expression of long term potentiation and memory formation
(74).
Immunoblot experiment shows that ribosomal protein is en-
riched in the PSD fraction. Previous electron microscopy re-
vealed the neuronal activity-dependent trafficking of polyribo-
somes to the vicinity of the PSD, but polyribosomes are not
embedded within the core structure of the PSD (75). Ribosomal
proteins therefore most likely are linked physically to the PSD
via the cytoskeletal proteins such as actin, which may explain
the rapid vectorial trafficking of these ribosomes toward the
PSD and also their localization close to the PSD (75).
Other proteins that may be involved in protein synthesis are
also detected, namely heterogeneous nuclear ribonucleoprotein
H, poly (rC) binding protein1, purine-rich element binding pro-
tein A, and enoyl-coenzyme A hydratase-like protein.
The eukaryotic elongation factor-1  (EF-1) is prominently
present in the preparation. This protein cooperates with other
initiation factors, EF-1, EF-1, and EF-1 to induce efficient
transfer of aminoacyl-tRNA to the ribosome. Initiation factor
5A is also characterized. This protein interacts with the 40 S
initiation complex and causes the hydrolysis of ribosome-bound
GTP. Finally, a low level of initiation factor 4 (IF-4) is detected.
A recent study indicated the presence of IF-4 in the dendritic
rafts and spines, and the protein was further shown to play an
important role in synaptic protein synthesis (76).
Among the proteins that are involved in protein synthesis,
EF-1 requires particular attention because it was reported
that the concentration of EF-1 in some cellular systems
greatly exceeds that of EF-1, -, and -, suggesting that it may
have distinct functions independent of the other members of
the elongation factor 1 family. Indeed, EF-1 has been shown
to bind and modulate activities of diverse signaling proteins
such as calmodulin (77), PLC-1 (78) and was shown to interact
with muscarinic acetylcholine receptors (79). The role of EF-1
in the PSD has not been examined. Our immunoblot study
reveals that EF-1 is highly enriched in the PSD preparation.
This is in contrast to IF-4, which has been shown previously to
be present throughout the dendrite (76). We propose that
EF-1 may be implicated in signaling events of the PSD, in
addition to its function in protein translation.
The Energy Production/Transfer Systems—Representative
proteins from two classes of energy production/transfer sys-
tems were characterized, namely proteins involved in the gly-
colytic pathway, and proteins involved in the production and
transfer of ATP (see also Refs. 12–13).
A number of enzymes involved in the glycolytic pathway are
present in the PSD fraction, i.e. glyceraldehyde-3-phosphate
dehydrogenase, triosephosphate isomerase, phosphoglycerate
mutase-1, and fructose-bisphosphate aldolase A. This is in
agreement with a previous study, which demonstrated by im-
munoelectron microscopy the presence of glyceraldehyde-3-
phosphate dehydrogenase in the dendritic spine and PSD (80).
It was postulated that these proteins provide immediate avail-
ability of glycolytic source of ATP to the synapse. This is espe-
cially important during acute increase in synaptic activity
when the mitochondrial supply of energy does not meet the
transient and highly localized increased demand in energy.
In addition to the proteins involved in glycolysis, we detect
proteins involved in energy generation, i.e. creatine kinase-B,
and in the phosphate transfer system, i.e. adenylate kinases.
These proteins play important roles in providing the site-spe-
cific burst of high energy phosphate (81). As these proteins are
present in the PSD, they are strategically situated to accom-
modate the burst of ATP requirement during an increase in
synaptic activity.
The Ubiquitination System—Previous studies indicated that
many PSD proteins are ubiquitin-conjungated (82). As the
ubiquitination/proteasome (Ub-Pr) pathway is a major route
used to regulate many critical cellular proteins that must be
rapidly destroyed (83), it was proposed that the Ub-Pr system
regulates the synaptic protein composition and thereby also
modulates functioning of the synapse (84). In line with this
hypothesis, it was reported that the Ub-Pr pathway in part
regulates the amount of syntaxin and G proteins, the endocy-
tosis of glutamate receptor from the membrane, and seems to
play a major role in regulation of synaptic plasticity (84–87). In
addition, malfunctioning of the Ub-Pr system may underlie a
number of degenerative disorders (83).
We have characterized several proteins from the PSD frac-
tions that are part of the Ub-Pr system, namely a novel protein
with high homology to the mouse ubiquitin-conjugating en-
zyme E2 that may play role in the conjugation of ubiquitin to
the proteins to be targeted to the proteasome, the proteasome
26 S subunit. Also we found ATPase 3, which is an essential
subunit of the core proteasome for the degradation of the ubiq-
uitin tagged proteins, and the ubiquitin C-terminal hydrolase
L1 which deubiquitinates proteins for recycling of free ubiq-
uitin or to remove ubiquitin from incorrectly tagged proteins.
The fact that many PSD proteins are ubiquitinated implies
that ubiquitin-conjugating enzymes must be (transiently) pres-
ent in the PSD. In this respect it may be biologically relevant
that both BAG-2 and CHIP (a putative E3 ubiquitin ligase, 88)
are present in the PSD as they might link the chaperone
system to the ubiquitination system.
The Receptors, Ion Channels, and Adhesion Proteins—These
classes of proteins are membrane bound and are identified
mainly by the ICAT LC-MS/MS experiment. Glutamate recep-
tors and ion channels are well described PSD constituents.
Neurofascin belongs to the family of ankyrin-containing mem-
brane-spanning cell adhesion molecules, and may link to the
spectrin-based system for membrane-cytoskeletal connection
(89). Brevican is a neural-specific chondroitin sulfate proteo-
glycan which functions as an extracellular matrix molecule,
and may be involved in synaptic plasticity (90). Plakoglobin is
similar to catenin . It is known that the cadherin-catenin
complex is involved primarily in cell-cell adhesion and regu-
lates the pre- and postsynaptic structures (91), and in addition
may also regulate intracellular transduction pathways.
The Presynaptic Proteins—Some presynaptic proteins are
recovered from the PSD preparation, as has been observed in
previous studies (18). Similar to previous reports, synapsins
are found in the PSD fraction. Synapsins may be co-purified
with the PSD due to their intrinsic property to interact with
high affinity to one of the major PSD proteins, namely CaMKII
(92). Interestingly, we reveal that synapsins are represented by
multiple spots i.e. 9 synapsin I and 14 synapsin II, suggesting
the presence of alternatively spliced isoforms and/or differen-
tially phosphorylated forms from single proteins. Furthermore,
we detect the recently described SNAP 25 interacting protein
30 in two protein spots (93), and Rabphilin-3A.
Concluding Remarks—The present study reveals a high di-
versity of functional classes of protein in the PSD fraction. This
is in agreement with previous electron microscopy studies that
showed the possible extension of the PSD into the spine com-
partment; the spine apparatus, polyribosomes, and specialized
endocytic zones are found located in close vicinity to the PSD
that together with other “cytosolic” proteins such as glycolytic
enzymes and signaling enzymes may be interconnected to the
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PSD by actin filament (75, 94–97). Together, we postulate that
the PSD is a complex organelle harboring diverse physiological
functions, which puts the PSD into a central position for the
autonomous functioning of the spine.
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